RIO DE JANEIRO, BRAZIL - After a meeting with President Jair Bolsonaro, an enthusiast of the treatment of Covid-19 with Chloroquine and Hydroxychloroquine, the Federal Council of Medicine (CFM) announced on Thursday, April 23rd, the authorization to administer drugs containing these substances in patients with mild cases. Mauro Ribeiro, president of CFM, met with Bolsonaro in the morning.
Despite acknowledging that there is still no evidence of safety and efficacy in the treatment, the body states that release occurs due to the exceptionality of the pandemic.
The CFM has cleared doctors prescribing the drug of ethical violations in three circumstances . . .